Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections - a Monocentric Prospective Observational Cohort Study

NCT05593874 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT05593874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05593874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections - a Monocentric Prospective Observational Cohort Study
Lead sponsor
University Hospital, Geneva
Phase
Observational
Overall status
Completed
Start date
October 10, 2022
Completion date
October 31, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic osteomyelitis, diabetic foot, septic arthritis